Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02838420 |
|---|---|
| Brief Title: | A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) |
| First Submitted : | July 18, 2016 |
| First Submitted that Met QC Criteria : | July 18, 2016 |
| First Posted : | July 20, 2016 (Estimate) |
| Results First Submitted : | May 29, 2019 |
| Results First Submitted that Met QC Criteria : | July 9, 2019 |
| Results First Posted : | July 11, 2019 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 4, 2024 |